Sign in
HS

HEALTHCARE SERVICES GROUP INC (HCSG)·Q1 2025 Earnings Summary

Executive Summary

  • HCSG delivered its strongest revenue and cash flow quarter in five years: Revenue $447.7M (+5.7% YoY), Diluted EPS $0.23, and cash flow from operations (CFO) ex payroll accrual $32.1M; management raised 2025 CFO (ex payroll accrual) guidance to $60–$75M from $45–$60M on strong collections and receipt of $12.2M in ERC funds .
  • Q1 results beat S&P Global consensus: Revenue $447.7M vs $443.9M consensus*, EPS $0.23 vs $0.188 consensus*, driven by new client wins, service execution, and cost discipline; adjusted EBITDA margin rose to 6.8% .
  • Outlook: Q2 revenue guided to $445–$455M and 2025 mid‑single‑digit growth reiterated; cost of services targeted at ~86% and SG&A at 9.5–10.5% near term (longer‑term 8.5–9.5%) .
  • Liquidity and capital deployment: $143.9M cash and marketable securities; $500M undrawn revolver; Q1 buybacks of ~$7M; first tuck‑in acquisition since 2021 to add ~1% to 2025 revenue .

Consensus estimates marked with * are from S&P Global.

What Went Well and What Went Wrong

  • What Went Well

    • “Best results in five years”: revenue and cash flow momentum carried into Q2; new client wins drove organic growth; collections exceeded revenue .
    • Margin execution: EVS margin at 10.8% and Dining at 7.6%; EBITDA and adjusted EBITDA improved, with adjusted EBITDA margin at 6.8% on service execution and field discipline .
    • Working capital and collections: DSO improved to 78 days (vs 88 days in Q1’24); collections strength underpinned raised 2025 CFO guidance (ex payroll accrual) to $60–$75M .

  • What Went Wrong

    • Inflation watchpoints: food‑at‑home inflation accelerated to ~1.0% QoQ; management will pass through per contracts but is working with clients to manage costs and menus .
    • Cash flow quality mix: Q1 CFO included a $12.2M ERC receipt; while not in income statement, it supported the guidance raise, making part of the CFO uplift non‑recurring .
    • Sequential revenue cadence sensitive to new business timing; excluding the ~1% M&A contribution, Q2 midpoint implies flattish sequential revenue, hinging on pipeline conversion and retention .

Financial Results

MetricQ3 2024Q4 2024Q1 2025
Revenue ($M)$428.1 $437.8 $447.7
Diluted EPS ($)$0.19 $0.16 $0.23
Net Income ($M)$14.0 $11.9 $17.2
Cost of Services ($M, %)$364.7 (85.2%) $379.2 (86.6%) $379.7 (84.8%)
SG&A ($M, % actual)$46.9; 10.4% actual $44.8; 10.1% actual $45.0; 10.4% actual
EBITDA ($M)$22.6 $17.9 $26.9
Adjusted EBITDA ($M, %)$24.8 (5.8%) $20.2 (4.6%) $30.6 (6.8%)

Segment revenue and margin

SegmentQ3 2024Q4 2024Q1 2025
Environmental/Housekeeping Revenue ($M)$191.1; margin 6.4% $192.7; margin 10.2% $196.3; margin 10.8%
Dining & Nutrition Revenue ($M)$237.0; margin 5.3% $245.1; margin 4.7% $251.3; margin 7.6%

KPIs and cash flow

KPIQ3 2024Q4 2024Q1 2025
Cash Flow from Operations ($M)$4.3 $36.2 $27.5
CFO ex payroll accrual ($M)$19.0 $27.0 $32.1
DSO (days)——78 (vs 88 in Q1’24)
Share Repurchases ($M)~$1.0 YTD Q3 item cited ~$1.0 in Q4; $16.0 since 2023 auth. ~$7.0 in Q1; $23.0 since auth.

Q1 2025 vs S&P Global consensus and prior periods

MetricQ1 2024Q4 2024Q1 2025 ActualQ1 2025 Consensus*Surprise*
Revenue ($M)$423.4 $437.8 $447.7 $443.9*+$3.8M (~+0.9%)*
EPS ($)$0.21 $0.16 $0.23 $0.1875*+$0.0425 (~+22.7%)*
EBITDA ($M)——$26.9 (Adj: $30.6) $25.1*+$1.8M vs EBITDA; +$5.5M vs Adj EBITDA*

Consensus estimates marked with * are from S&P Global.

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
CFO from Operations (ex payroll accrual)FY 2025$45–$60M (Q4 2024) $60–$75M (Q1 2025) Raised
RevenueQ2 2025—$445–$455M New
Revenue GrowthFY 2025Mid‑single digit Mid‑single digit reiterated Maintained
Cost of Services TargetOngoing~86% ~86% Maintained
SG&A (% of revenue)Near term9.5–10.5% 9.5–10.5%; LT goal 8.5–9.5% Maintained
Acquisition ContributionFY 2025—~1% of FY revenue New

Earnings Call Themes & Trends

TopicQ3 2024 (Prior-2)Q4 2024 (Prior-1)Q1 2025 (Current)Trend
Regulatory/minimum staffing ruleAnticipated revision/elimination; litigation ongoing Expect revision/elimination; positive admin backdrop Texas federal court struck down key provisions; industry sentiment positive Improving clarity, reduced overhang
Collections/DSOCollections >98.5%; strong Q4 expected Q4 collections >100% helped CFO DSO 78 days (from 88); collections exceeded revenue Sustained improvement
Labor availabilityRecovery toward pre‑pandemic; rural lag Stabilizing wages; improving availability Healthcare sector hiring strong; stabilization continues Improving
Food inflationQ3: modest inflation resumed Q4: food-at-home inflation rose QoQ Q1: food-at-home +1.0% QoQ; pass-through in place Mixed; monitoring
Growth pipeline/cross‑sellDemand strong; balanced EVS/Dining Mid‑single‑digit growth plan; mgmt trainee pipeline New client wins; Q2 guide depends on add timing Positive; timing variable
Capital allocationBuybacks ongoing; capacity available Organic first; M&A optionality; opportunistic buybacks ~$7M buybacks; first tuck‑in since 2021 More active
Education segment<5% revenue; seasonal; growing Growth opportunity; supplementary to core Continues as complementary growth vector Gradual expansion

Management Commentary

  • “First quarter revenue and cash flows were our best results in five years… New client wins drove our organic growth, collections exceeded revenue, and we continued to strengthen our balance sheet.” — CEO Ted Wahl .
  • “We estimate Q2 revenue in the range of $445 million to $455 million… and expect second half revenue to grow sequentially vs. first half.” — Matt McKee .
  • “DSO… was 78 days versus 88 days at the end of Q1 2024… revenues have increased each quarter and our gross receivables have declined consecutively.” — CFO Vikas Singh .
  • “We raised our 2025 cash flow from operations expectations… from $45–$60 million to $60–$75 million.” — Matt McKee .
  • “This is our first acquisition since late 2021… 2025 revenue impact about 1%.” — CFO Vikas Singh .

Q&A Highlights

  • Regulatory environment: Management emphasized a nationwide ruling striking key provisions of CMS minimum staffing requirements as removing an overhang; broader reimbursement sentiment remains positive under the new administration .
  • Margin sustainability: Q1 margins above targets driven by service execution (customer experience, systems adherence, regulatory compliance, budget discipline); SG&A to track 9.5–10.5% near term as growth investments support margins .
  • Inflation dynamics: Food‑at‑home inflation accelerated to ~1.0% in Q1; HCSG has pass‑through provisions but works with clients on menu flexibility; labor market stabilization continues .
  • Revenue cadence: Q2 midpoint implies minimal sequential growth excluding M&A; variability driven by timing of new business adds; full‑year mid‑single‑digit growth reiterated .
  • Cash flow guidance raise: Increase reflects both ERC receipt (~$12.2M) and strong collections momentum; management confident in sustaining collections trends .

Estimates Context

ItemQ1 2025 ActualQ1 2025 Consensus*Surprise*
Revenue ($M)$447.7 $443.9*+$3.8M (~+0.9%)*
EPS ($)$0.23 $0.1875*+$0.0425 (~+22.7%)*
EBITDA ($M)$26.9 (Adj: $30.6) $25.1*+$1.8M vs EBITDA; +$5.5M vs Adj EBITDA*
  • FY 2025 consensus: Revenue ~$1.838B*, EPS ~$0.809*; after Q1 beat and CFO guidance raise, estimate risk skews modestly upward for cash flow and potentially EBITDA, while revenue trajectory aligns with mid‑single‑digit growth and Q2 guidance .
    Consensus estimates marked with * are from S&P Global.

Key Takeaways for Investors

  • Operational inflection: Strongest revenue and cash flow in five years with broad‑based margin execution; adjusted EBITDA margin expanded to 6.8% .
  • Quality of cash flow: Underlying collections momentum is real (DSO to 78; collections > revenue), though Q1 CFO also benefited from ~$12.2M ERC; guidance raise reflects both .
  • Near‑term top line: Q2 guide ($445–$455M) implies flattish sequential revenue excluding M&A; quarterly cadence depends on timing of new business adds, but mid‑single‑digit FY growth intact .
  • Margin framework: Cost of services managed toward ~86%; SG&A 9.5–10.5% near term to support growth initiatives; continued leverage opportunity as top line scales .
  • Capital allocation: Healthy liquidity ($143.9M cash + securities; $500M undrawn revolver), active buybacks (~$7M in Q1), and first tuck‑in since 2021 (~1% of 2025 revenue) position HCSG to balance organic and inorganic growth .
  • Regulatory backdrop: Minimum staffing rule risk materially reduced by Texas ruling applied nationwide; industry sentiment constructive, supporting demand for outsourced services .
  • Trading implications: The clear EPS/revenue beat vs consensus*, CFO guidance raise, and reduced regulatory overhang are positive catalysts; focus near term on pipeline conversion and margin execution sustaining mid‑year momentum .

Consensus estimates marked with * are from S&P Global.